Fusion Antibodies Ltd (FAB) ORD GBP0.04
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
n/a
n/a
7.38p
£4.03 million
4.20p
n/a
2.90p
n/a
0.05p (1.18%) Previous:
0.05p
n/a
n/a
30,000
Performance
| 1 week 1W | 1.18% | 1 year 1Y | 28.51% |
|---|---|---|---|
| 1 month 1M | 0% | 2 years 2Y | 90.77% |
| 3 months 3M | 35.48% | 3 years 3Y | 96.5% |
| 6 months 6M | 12% | 5 years 5Y | 94.51% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/03/2024 | 31/03/2023 |
|---|---|---|
| Revenue (£m) | 1.14 | 2.90 |
| Profit before tax (£m) | (2.29) | (2.86) |
| Adjusted EPS (p): | (3.90) | (10.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies reports positive recent trading
8 October 2024 15:40
-
Fusion Antibodies strengthens financial position despite revenue decline
5 September 2024 13:53
-
Fusion Antibodies 'on track and on plan' following positive Q1 performance
4 July 2024 09:50
-
Half-year Report
19 November 2024 07:00
-
Director/PDMR Shareholding
16 October 2024 13:23
-
Issue of shares to non-executive directors
16 October 2024 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.